cbdMD (NYSEAMERICAN:YCBD) Earns “Hold” Rating from Maxim Group

cbdMD (NYSEAMERICAN:YCBD)‘s stock had its “hold” rating reiterated by investment analysts at Maxim Group in a research note issued on Monday,Benzinga reports.

cbdMD Stock Performance

Shares of NYSEAMERICAN:YCBD opened at $0.50 on Monday. The company has a 50-day simple moving average of $0.64 and a 200 day simple moving average of $0.74. cbdMD has a 52-week low of $0.47 and a 52-week high of $2.56.

cbdMD (NYSEAMERICAN:YCBD) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.08). The business had revenue of $5.55 million during the quarter, compared to the consensus estimate of $5.69 million. cbdMD had a negative net margin of 13.80% and a negative return on equity of 34.26%.

Institutional Trading of cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC bought a new stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned 0.49% of cbdMD as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 7.18% of the company’s stock.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.